Global atopic dermatitis drugs market

SKU ID : MMR- 13386098

Publishing Date : 08-Apr-2019

No. of pages : 280


  • Global atopic dermatitis drugs market was valued US$ 3.8 Bn in 2017 and is expected to reach US$ 5.42 Bn by 2026, at a CAGR of 4.54% during a forecast period.

    Atopic dermatitis is a medical disorder, which often seems like a red, itchy, and rash normally on the cheeks, arms and legs. It's generally growing in early childhood and is more common in people who have a family history of the disorder. Atopic dermatitis is chronic & tends to flare periodically and it may be accompanied by asthma & hay fever. Treatment includes for atopic dermatitis are avoiding soap & other irritants and certain creams & ointments may also provide relief from the itching as well rashes.

    Rising occurrence of food allergies exacerbating atopic dermatitis, increasing focus on systematic therapies, and the growing use of pharmacological products in developing countries are boosting the growth of the atopic dermatitis drugs market. Major limiting factors of the global atopic dermatitis drug market are side effects, the high cost of treatment, and a dearth of good & safe therapeutics.

    The topical route of administration segment is accounted for the largest market share and lead the market during the forecast period owing to the most effective treatment with the least side effects, high patience adherence, cost-effectiveness, and less pain. A topical medication is applied to body surfaces such as the skin and mucous membranes to treat ailments through a large range of classes including creams, foams, gels, lotions, and ointments.

    An oral segment is the most frequently used route of drug administration and is the most appropriate and cost-effective. Although solid-dose forms like tablets & capsules have a high degree of drug stability & provide accurate dosage, the oral route is problematic due to the unpredictable nature of gastrointestinal absorption.

    North America is expected to hold the largest share during the forecast period owing to the growing cases of atopic dermatitis in children is the rising prevalence of food & skin allergies. Furthermore, new product launches in the US are also expected to generate large revenue and drive market growth in the region.

    The major market players in the global atopic dermatitis drugs market are Leo Pharma, Meda Pharmaceuticals, Valent Pharmaceutical Inc., Bayer Ag, and Encore Dermatology.

    The report covers a comprehensive study of major market drivers, restrains, opportunities, challenges, PESTEL, Porters, SWOT, and technological forecasting in the market.
    The Scope of Global Atopic Dermatitis Drugs Market:
    Global Atopic Dermatitis Drugs Market, by Therapy:
    Photo Therapy
    Directed Therapy
    Global Atopic Dermatitis Drugs Market, by Route of Administration:
    Global Atopic Dermatitis Drugs Market, by End User:
    Research Labs
    Global Atopic Dermatitis Drugs Market, by Region:
    North America
    South America
    Middle East & Africa
    Key Player Operating In the Global Atopic Dermatitis Drugs Market:
    LEO Pharma
    Bayer HealthCare
    Encore Dermatology
    Novartis AG
    Valent Pharmaceutical Inc.
    Astellas Pharma Inc.
    Meda AB
    Bayer Ag
    Encore Dermatology

    Frequently Asked Questions

    This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

    • By product type
    • By End User/Applications
    • By Technology
    • By Region

    The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
    market Reports market Reports